Multiple signal pathways in the leukemogenesis and therapeutic implications

Leukemia Research

Volumn 31, Issue 12, 2007, Pages 1759-1760

  Chen, Jiezhong ^a   McMillan, Nigel A J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

bcl2; c myc; Multiple signal pathway

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MYC PROTEIN; PROTEIN BCL 2; RAPAMYCIN; RITUXIMAB;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; GENE OVEREXPRESSION; HUMAN; LEUKEMIA; LEUKEMOGENESIS; LYMPHOMA; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 35948978483     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.04.006     Document Type: Note

References (15)

1. Taira T., Nagasaki A., Tomoyose T., et al. Establishment of a human herpes virus-8-negative malignant effusion lymphoma cell line (STR-428) carrying concurrent translocations of BCL2 and c-MYC genes. Leuk Res 31 (2007) 1285-1292
2. Handa H., Hegde U.P., Kotelnikov V.M., et al. Bcl-2 and c-myc expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase. Leuk Res 21 6 (1997) 479-489
3. Pattingre S., and Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?. Cancer Res 66 6 (2006) 2885-2888
4. Sansom O.J., Meniel V.S., Muncan V., et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446 7136 (2007) 676-679
5. Dmitrovsky E., Kuehl W.M., Hollis G.F., et al. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322 6081 (1986) 748-750
6. Khan I.H., Mendoza S., Rhyne P., et al. Multiplex analysis of intracellular signaling pathways in lymphoid cells by microbead suspension arrays. Mol Cell Proteom 5 4 (2006) 758-768
7. Calin G.A., Ferracin M., Cimmino A., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353 17 (2005) 1793-1801
8. Bichi R., Shinton S.A., Martin E.S., et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 99 10 (2002) 6955-6960
9. Planelles L., Carvalho-Pinto C.E., Hardenberg G., et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 6 4 (2004) 399-408
10. Kornblau S.M., Womble M., Qiu Y.H., et al. Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia. Blood 108 7 (2006) 2358-2365
11. Jennings B.A., and Mills K.I. c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia. Leuk Res 22 10 (1998) 899-903
12. Ghobrial I.M., Witzig T.E., and Adjei A.A. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55 3 (2005) 178-194
13. Majumder P.K., Febbo P.G., Bikoff R., et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 10 6 (2004) 594-601
14. Jazirehi A.R., Vega M.I., and Bonavida B. Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy. Cancer Res 67 3 (2007) 1270-1281
15. Smalley K.S., Haass N.K., Brafford P.A., et al. Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases. Mol Cancer Ther 5 5 (2006) 1136-1144